期刊文献+

妊娠高血压综合征胎盘组织差异表达基因的筛选与确定 被引量:7

Screening and confirmation of differentially expressed genes in placentas from PIH patients
原文传递
导出
摘要 目的 了解妊娠高血压综合征 (妊高征 )胎盘组织基因表达的改变 ,确定与妊高征发病相关的基因 ,为研究妊高征的发病机理提供线索。 方法 收集 2 0 0 1年 3月至 2 0 0 2年 9月西安地区以剖宫产终止妊娠的 4 2例妊高征患者及 2 2例正常产妇的产前、产后临床资料 ;收集胎盘组织 ,制作胎盘组织芯片 ;建立妊高征患者数据库。采用抑制消减杂交技术 (suppressionsubtractivehybridi za tion ,SSH)建立妊高征胎盘组织cDNA消减文库 ;利用差异筛选技术筛选出妊高征胎盘高表达基因 ,用RT PCR和免疫组织化学技术验证部分高表达基因。 结果 建立了由 4 2例中、重度妊高征患者和 2 2例正常产妇组成的数据库 ;用 6 6例胎盘组织制成 15 0点的胎盘组织芯片。利用SSH和差异筛选共分离出 10 3个阳性克隆 ,测序成功 90个。测序结果显示 90个cDNA片断与GenBank/EMBL中36条已知功能基因有 95 %以上的同源性。 结论 妊高征患者胎盘组织基因表达发生较大变化 ;有必要研究血管内皮生长因子受体、卵巢抑制素、丝氨酸蛋白酶抑制素、细胞角蛋白 7以了解妊高征的发病机理。 Objective To unmask clues for the investigation of PIH pathogenesis by detecting the altered gene expression profile of placentas from PIH patients. Methods Clinical data and placentas were collected from 42 PIH patients and 22 normotensive pregnancies in seclective cesarean section to construct PIH database from Mar. 2001 to Sep. 2002 in Xi’an district. Suppression subtractive hybridization (SSH) was performed to set the subtractive cDNA library and differential screening was used to identify the positive clones;insertion of positive clones were sequenced by T7 primer method. RT-PCR and immunohistochemistry were employed to confirm the putative gene inhibin A expression. Results A database was set up that consists of pre- and postpartum clinical data and placenta samples of 42 preeclamptic pregnancies and 22 normotensive ones From which,150 features of placental tissue microarray were made. One hundred and three positive clones were isolated by SSH and differential screening. Sequencing and BLAST analysis showed that 90 insertion shared more than 95% homology with sequences in the GenBank/EMBL database. We identified 36 putative genes including pregnancy-specific glycoproteins gene (BC005924),serine protease inhibitor gene (BC012868),VEGFR-1 gene (AF063657),cytokeratine 7 gene(CK7) (AF509887),etc. Inhibin beta A gene was highly expressed in placentas in PIH patients. Conclusion The gene expression profile in PIH placenta was greatly changed;it might be necessary to investigate the role of VEGFR1,serine protease inhibitor,inhibin and CK7 in the pathogenesis of PIH.
出处 《中华围产医学杂志》 CAS 2004年第4期201-205,i001,共6页 Chinese Journal of Perinatal Medicine
基金 国家自然科学基金资助项目 ( 3 0 0 70 787)
关键词 妊娠高血压综合征 胎盘组织差异表达 基因 筛选 核酸杂交 Pregnancy complications,cardiovascular Hypertension Placenta Gene expression profiling Nucleic acid hybridization
  • 相关文献

参考文献16

  • 1Maynard SE, Min JY, Merchan J, et al. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest,2003,111:649-658.
  • 2Sugimoto H, Hamano Y, Charytan D, et al. Neutralization of circulating vascular endothelial growth factor (VEGF) by anti-VEGF antibodies and soluble VEGF receptor (sFlt-1) induces proteinuria. J Biol Chem,2003,278:12605-12608.
  • 3Vaillant P, David E, Constant I, et al. Validity in nulliparas of increased beta-human chorionic gonadotrophin at mid-term for predicting pregnancy-induced hypertension complicated with proteinuria and intrauterine growth retardation. Nephron,1996,72:557-
  • 4Smith GC, Stenhouse EJ, Crossley JA, et al. Early pregnancy levels of pregnancy-associated plasma protein A and the risk of intrauterine growth restriction, premature birth, preeclampsia,and stillbirth. J Clin Endocrinol Metab, 2002, 87: 1762-1767.
  • 5Takemasa I, Higuchi H, Yamamoto H, et al. Construction of preferential cDNA microarray specialized for human colorectal carcinoma: molecular sketch of colorectal cancer. Biochem Biophys Res Commun, 2001, 285: 1244-1249.
  • 6Diatchenko L, Lau YF, Campell AP, et al. Suppression subtractive hybridization: a method for generating differentially regulated or tissue-specific cDNA probes and libraries. Proc Natl Acad Sci,1996,93:6025-6030.
  • 7Bussolati B, Dunk C, Grohman M, et al. Vascualr endothelial growth factor receptor-1 modulates vascular endothelial growth factor mediated angiogenesis via nitric oxide. Am J Pathol,2001,159:993-1008.
  • 8Livingston JC, Chin R, Haddad B, et al. Reductions of vascular endothelial growth factor and placenta growth factor concentrations in severe preeclampsia. Am J Obstet Gynecol,2000,183:1554-1557.
  • 9Sharkey AM, Charnock-Jones DS, Boocock CA, et al. Expre-ssion of mRNA for vascular endothelial growth factor in human placenta. J Reprod Fertil,1993,99:609-615.
  • 10Kendall RL, Thomas KA. Inhibition of vascular endothelial cell growth factor activity by an endogenously encoded soluble receptor. Proc Natl Acad Sci,1993,90:10705-10709.

同被引文献102

引证文献7

二级引证文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部